Wednesday, February 10, 2010, 9:21pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

DepoMed Inc. (DEPO)

At 5:00AM SGT: 2.90 USD   0.00 (0.00%)  
 MORE ON DEPO 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Depomed, Inc. (NGM:DEPO) Delayed quote dataEdit
Last Trade:2.90 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:2.90
Open:N/A
Bid:1.78 x 500
Ask:4.98 x 1000
1y Target Est:7.83
Day's Range:N/A - N/A
52wk Range:1.66 - 6.40
Volume:0
Avg Vol (3m):284,597
Market Cap:150.83M
P/E (ttm):N/A
EPS (ttm):-0.58
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add DEPO to Portfolio   Download Data

 HEADLINES 
•Depomed to Present at the 12th Annual BIO CEO & Investor Conference
Business Wire (Tue, Feb 2)
•Depomed Announces Allowance of U.S. Patent Covering Gastric Retentive Gabapentin Dosage Forms
Business Wire (Mon, Feb 1)
•Depomed Announces Receipt of $500,000 Milestone Payment from Covidien for the Development of a Second Formulation
Business Wire (Thu, Jan 21)
•DEPOMED INC Files SEC form 8-K, Other Events
EDGAR Online (Thu, Jan 21)
•UPDATE - Depomed to conduct another trial for hot flashes drug
at Reuters (Tue, Jan 19)
•Depomed Comments on FDA Guidance and Plans for One Additional Phase 3 Clinical Trial Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes
Business Wire (Tue, Jan 19)
•5 Cold Stocks Heating Up
at Motley Fool (Sat, Jan 16)
•DEPOMED INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Sat, Jan 9)
•Neutral on Santarus
Zacks.com (Wed, Jan 6)
•Zacks #5 Rank Additions for Wednesday
Zacks.com (Wed, Jan 6)
•Huge Leaps for Small-Cap Pharma Plays
Indie Research (Tue, Dec 15)
•Prospecting for Stocks: DepoMed
at Motley Fool (Tue, Dec 8)
More Headlines for DEPO...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.49
EPS Est (in 2 years) (Dec-10) :-0.49
Avg Rec (current)*:1.8
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices